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The anesthetic propofol and other exhaled organic compounds can be sampled in Tenax sorbent tubes and analyzed by gas
chromatography coupled with mass spectrometry. The aim of this study was to evaluate the stability of propofol in Tenax sorbent
tubes during overseas shipping. This is relevant for international pharmacokinetic studies on propofol in exhaled air. Tenax sorbent
tube propofol samples with concentrations between 10 and 100 ng were prepared by liquid injection and with a calibration gas
generator. For each preparation method, one reference set was analyzed immediately after preparation, a second set was stored at
room temperature, and a third one was stored refrigerated.The fourth set was sent fromGermany by airmail to USA and back.The
shipped set of tubes was analyzed when it returned after 55 days elapsed.Then, the room temperature samples and the refrigerated
stored samples were also analyzed. To evaluate the stability of propofol in the stored and shipped tubes, we calculated the recovery
rates of each sample set. The mean recovery in the stored samples was 101.2% for the liquid preparation and 134.6% for the gaseous
preparation at 4∘C. At 22∘C, the recovery was 96.1% for liquid preparation and 92.1% for gaseous preparation, whereas the shipped
samples had a recovery of 85.3% and 111.3%.Thus, the deviation of the shipped samples is within a range of 15%, which is analytically
acceptable. However, the individual values show significantly larger deviations of up to -32.1% (liquid) and 30.9% (gaseous). We
conclude that storage of propofol on Tenax tubes at room temperature for 55 days is possible to obtain acceptable results. However,
it appears that due to severe temperature and pressure variations air shipment of propofol samples in Tenax tubes without cooling
shows severe deviations from the initial concentration. Although it was not tested in this study, we assume that refrigerated transport
might be necessary to obtain comparable results as in the stored samples.
1. Introduction
Propofol is one of the most commonly used intravenous
anesthetics. Due to the high volume of distribution and
the high clearance, relatively high plasma concentrations are
required for adequate anesthesia. However, there is no fast
method for determining the plasma concentration of the
agent during anaesthesia. Since propofol is volatile and the
blood and alveolar space are in equilibrium after a defined
time, the drug is exhaled during anesthesia [1]. Several studies
have shown a good correlation between the exhaled and
plasma propofol concentration [2, 3].
Online measurement of propofol concentrations in
exhaled air is an innovative approach for personalized dosage.
The opportunity for this promising technique has now
emerged due to a new mobile ion mobility spectrometry
device (EDMON, Exhaled Drug Monitor; B. Braun Melsun-
gen,Melsungen, Germany) on themarket.Worldwide studies
are expected to establish pharmacological models for the
prediction of propofol concentrations in blood from breath
concentration since a direct inference from the breath to the
blood level is not possible as exhaled concentrations adapt to
changes in the plasma concentration with a time delay when
concentrations are not in steady state [4].
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Nevertheless, the gold standard for such analyses is
the gas chromatography with coupled mass spectrometer
(GCMS). It serves as a reference method for other meth-
ods such as the ion mobility spectrometry. Therefore, in
addition to IMS measurements, GCMS measurements are
also necessary to allow cross-validation of the results. A
GCMS with thermal desorption system (TDS) allows direct
sampling of exhaled air on Tenax sorbent tubes and quan-
tification without further sample preparation [5]. However,
the method requires expensive equipment and considerable
expertise. Therefore, TDS-GCMS systems are only available
in specialized centers, so shipping of patient samples is
unavoidable.
In a recent study, we demonstrated that propofol is
storable on Tenax sorbent tubes for at least two weeks at
ambient temperature [6]. Overseas shipping, however, often
takes longer and is characterized by significant variations
in atmospheric pressure and temperature, as well as strong
vibrations. It is unknown whether propofol concentrations
remain stable during air shipments. We, thus, tested the
hypothesis that propofol concentrations in Tenax tubes
remain stable when sent by airfreight from Germany to the
United States and back.
2. Materials and Methods
2.1. Sample Preparation with a Stock Solution. We dissolved
propofol (97%, Sigma Aldrich, Munich, Germany) in HPLC-
grade water (VWR, Darmstadt, Germany) to a 50 𝜇g/mL
propofol stock solution. The stock solution was gravimet-
rically diluted in 50 mL flasks to 5, 10, 20, and 50 𝜇g/mL
samples. 2 𝜇L from each standard or HPLC-grade water
for blanks, respectively, was directly pipetted onto Tenax
sorbent tubes as quadruplicate per sample. The mass of
each injection was determined on a Cubis analytical scale
(Sartorius, Göttingen, Germany) to determine the exact
amount of propofol injected in ng. The resulting samples
contained final propofol masses of 10, 20, 50, and 100 ng.
For an even distribution of propofol, each tube was flushed
after injection for 30 seconds with 1 bar of 99.999% pure
synthetic air (Air Liquide, Düsseldorf, Germany) (20.5% O
2
purity [4.5], 79.5 % N
2
purity [5.0]). To test whether propofol
is lost during loading, a second Tenax sorption tube was used
to investigate the synthetic air exiting the end of the loaded
tube. We calibrated on the day of shipment and immediately
after their return, with eight calibration standards (0, 10, 20,
30, 40, 50, 60, and 100 ng) prepared on the day of calibration,
which were pipetted as stated above.
2.2. Sample Preparation with Calibration Gas Generator. A
90 𝜇g/mL propofol stock solution was prepared as described
[6] with addition of 1% v/v HPLC-grade ethanol (Sigma-
Aldrich GmbH, Steinheim, Germany). The gas generator was
a HovaCAL 4836-VOC (IAS GmbH, Oberursel, Germany)
[7].The propofol stock solution was injected via two syringes
(1702.5TLLX,Hamilton Co., Reno, USA), each with a volume
of 50 𝜇L and vaporized at 100∘C. The Tenax sorbent tubes
were loaded by aspirating 0.3 L propofol gas with a flow of
0.4 L∙min−1 through a Bivoc2 gas sampling pump (Holbach
GmbH, Wadern, Germany).
Tenax sorbent tubes with a total amount of 20, 40,
60, 80, and 100 ng of vaporized propofol were prepared
as quadruplicate per sample. After every change of the
propofol output concentration, the reference gas generator
was operated for 5 minutes before sampling to ensure the
equilibration at the designated concentration.
We calibrated on the day of shipment and immediately
after their return, with five calibration standards (20, 40, 60,
80, and 100 ng) prepared on the day of calibration, whichwere
prepared as mentioned above.The sampling method in detail
and HovaCAL parameters are mentioned elsewhere [6]. The
agreement between both sampling preparation methods is
mentioned elsewhere [6].
2.3. Storage and Shipment of Samples. Each sample was
prepared as quadruplicate on the day of shipment and
randomly assigned to one of four groups. The reference
samples were analyzed immediately after their preparation.
Two sets of samples were stored at 21∘C and 4∘C, respectively,
and analyzed after 55 days. The mailed samples were sent
to Cleveland, Ohio, USA, and analyzed upon return after 55
days.
Every TDS-Tube was stored in its respective tube con-
tainer and anoverpack. Adata logger (Log32THP,Dostmann,
Wertheim, Germany) was added to the stored and shipped
samples to record temperature and pressure variations in the
interval of five minutes. The amounts for the reference sam-
ples were calculated with the calibration at the beginning of
the experiment. Amounts for stored andmailed samples were
determined with calibration at the end of the experiment.
2.4. GC-MS. We quantified propofol using a 7890B gas
chromatograph (Agilent, Santa Clara, United States) with a
5977B quadrupole mass spectrometer (Agilent, Santa Clara,
United States) and an XTr EI 350 ion extraction lens. For
sample preparation and application into the GC-MS, we used
Tenax sorbent tubes (Tenax GR, Gerstel, Mühlheim, Ger-
many). A coupled TDSA2 auto sampler (Gerstel, Mühlheim,
Germany) with a TDS3 thermal desorption system (Gerstel,
Mühlheim, Germany) and a KAS6 cold injection system
(Gerstel, Mühlheim, Germany) was used for injection. The
carrier gas was helium (99.9999%, Air Liquide Deutschland
GmbH, Düsseldorf, Germany). For separation we used a
capillary column of the type HP-5MS UI (30 m x 0.25 mm,
film thickness 0.25 𝜇m, Agilent Technologies, Santa Clara,
United States) and a column flow of 1.2 mL/min. The column
temperature program started at 50∘C with a temperature
ramp of 20 K/min and a final temperature of 260∘C for 1
min. The thermal desorption program had a ramp rate of 20
K/min with a final temperature of 240∘C for 4 min, unsplit
sample, and a desorption flow 40 mL/min.The cold injection
conditions were -50∘Cwith a temperature ramp of 12 K/s and
a final temperature of 250∘C for 3min, 20:1 injection split.The
mass spectrometer conditions were full scan m/z between 50
and 300, transfer tube temperature 250∘C, quadrupole tem-
perature 150∘C, ion source temperature 230∘C, and solvent
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Figure 2: Pressure course for the stored samples (red line) and the mailed samples (black line).
delay 4 min. Propofol has a retention time (RT) from 7,489
to 7,501 min in this setup [6].
2.5. Data Analysis. For data analysis, we used the pro-
grams Qualitative Analysis (ver. B.07.000) and Quantitative
Analysis (ver. B.07.01 SP1) (Agilent Technologies). For peak
identification, the NIST-Database was applied. As quantifier
and qualifier ions, m/z 163 and m/z 178 were used. The
percentage deviation, which defines the acceptable range for
the quantifier to qualifier ratio, was set at 20%.Themeasured
peak area of propofol was plotted vs. the known weighed
masses of propofol, respectively, vs. known ppbv of propofol.
Slope and intercept were determined from a least-squares
linear regression. For the linear regression, the acceptable R2
minimum was set at 0.985.
The recovery was calculated according to the equation
(𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑚𝑎𝑠𝑠 − 𝑤𝑒𝑖𝑔ℎ𝑒𝑑 𝑚𝑎𝑠𝑠) ∗ 100
𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑚𝑎𝑠𝑠
(1)
2.6. Statistical Analysis. SigmaPlot (version 12.5, Systat Soft-
ware, Erkrath, Germany) was used for statistical analysis. A
Bland and Altman analysis was performed to evaluate the
agreement between different sample groups.
3. Results
3.1. Tenax Sorbent Tubes. Every tube yielded an analyzable
chromatogram. No peak interferences were observed around
the retention time of propofol (RT=7.5 min) (Figure 1).
Besides the usual Tenax degradation products, such as phenol
(RT = 4.5 min), acetophenone (RT = 5.3min), benzoic acid
(RT = 6.1min), and phthalic anhydride (RT = 7.2 min) [8],
propofol was always the only sharply demarcated signal.
The propofol quantifier peak (base peak 163 m/z) to
qualifier peak (molecule peak 178 m/z) ratio has always met
our analyzing criteria and gained a mean value of 29.4 ± 5%
SD.
Figure 2 shows the pressure course for both the stored and
the mailed samples over the shipping time. Latter samples
were transported on three flights with a minimum total
pressure of ∼800 hPa, which resembles ∼80% of the normal
atmospheric pressure.The stored samples were not subject to
strong pressure fluctuations.
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Figure 3: Temperature course for the stored samples (red line) and the mailed samples (black line).
Figure 3 shows the temperature course for stored and
mailed samples. The mailed samples experienced some tem-
perature spikes up to 60∘C during transportation and peri-
odical changes in temperature at around room temperature,
which is likely due to the day-and-night cycles. The stored
samples remained at ambient temperature throughout.
The measured amounts of propofol are shown in Table 1.
The mailed samples had a mean recovery of 85.3% for the
liquid preparation and 111.3% for the gaseous preparation. In
contrast, the stored samples showed average recovery rates of
101.2% and 134.6% at 4∘C and 96.1%, respectively, and 92.1% at
22∘C. Figure 2 shows the differences between the stored and
mailed samples, respectively, and the reference samples that
were analyzed immediately.
The comparison of the mailed samples vs. reference
samples (Figures 4(b) and 4(d)) shows a trend to negative
differences for the liquid application at higher propofol
concentrations, whereas the gaseous applicated samples show
no tendency. At least, it is clear that the propofol is not lost
during the loading process, since a second sorbent tube was
used to confirm that the synthetic air escaping at the end of
the tube does not contain any propofol.
The data for the chilled samples show a greater deviation
than the samples stored at room temperature for both
application methods (Figures 4(a) and 4(c)) and a significant
overestimation of the propofol amount for the gaseous
samples (Figure 4(c)).
4. Discussion
The total delivery time of Tenax sorption tubes was 55 days.
Over this period, ambient air storage resulted in acceptable
mean recovery rates for liquid applicated samples. However,
airfreight shipping, on the other hand, was associated with
a significant loss of propofol in liquid applied, but not
in gaseous applied samples. Even storage of liquid applied
samples at room temperature resulted in a much lower loss
than air freight.
In principle, the differences in the recovery rates could
be due to the storage time itself, on the one hand, and the
pressure and temperature fluctuations during air transport,
on the other hand. Naturally, a stronger diffusion and des-
orption rate is expected at higher propofol concentration on
the tubes. The transported samples were repeatedly exposed
to high temperatures of over 60∘C. We can only specu-
late about the reasons. The samples may have been stored
between flights in uncooled freight centers. Furthermore, low
pressure during long-haul flights (∼800 hPa and ∼825 hPa)
and vibrations may explain the loss of propofol during air
transport. However, why this loss affects more strongly the
liquid samples is unclear. It would be conceivable that the
gaseous application leads to a more uniform distribution of
the propofol on the surface of the adsorbent and thus to
a better analyte retention than a liquid solution dropped
locally on the Tenax. Whether that explains the differences
is not clear, but the gaseous samples are more similar in
their nature to real breath samples and therefore particularly
important for evaluating durability during air transport. The
liquid application method has the advantage that the mass
of propofol can be weighed exactly on the tube. Therefore, it
provides accurate control of the amount of propofol. For the
gaseous application, this is clearly not possible, although this
technique is less cumbersome and closer to the real breath
sample.
Considering the recovery rate in the reference samples,
it can be assumed that even without storage or shipping
due to measurement inaccuracies and errors during loading
and weighing of the samples a mean error of around ±7.5%
can occur. With regard to our validated method inaccuracy
[5] of ∼ 6.5 RSD%, data within a range of 13% RSD are
within the inaccuracy of the TDS-GCMS method since the
comparison with the reference must be based on double the
RSD due to inaccuracies of both the calibration standards
and the samples. This may explain the recovery rates of the
refrigerated samples which were almost all >100% despite a
storage period of 55 days.
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Figure 4: Comparison of stored (a, c) and mailed (b, d) samples with the reference Tenax tube samples for both application methods: liquid
(a, b) and gaseous (c, d). Difference plots with stored samples (22∘C blue dots; 4∘C red triangles) vs. direct measured reference samples (a, c)
andmailed samples vs. direct measured reference vs. (turquoise rectangles) (b, d).The dashed lines represent the mean of the differences and
the solid lines represent the mean of the difference ± 1.96 SD.
In a clinical setup, exhaled air concentrations in a range of
50 ppbv (corresponding 110 ng) can be expected at maximum
[6, 9]. As our own clinical measurements on patients during
propofol anesthesia show, the measured concentrations in
exhaled air are mostly between 0 and 22 ng, which is within
the range we studied now. For the shipped tubes, however,
there are samples with a difference of over 30% compared to
the reference, which corresponds to 16 ng. Looking now at
the relevant measuring range of 0-22 ng, these deviations are
far outside the usual tolerances of 10-15%. This suggests that
the air transport might be possible for exhaled air without
affecting the propofol amount but is not possible with the
approach we have chosen.
Nevertheless, the study has several limitations. Unfor-
tunately, refrigerated air transport has not been tested for
cost reasons, although chilled storage is published to have
a more consistent analyte retention than uncooled storage
[10]. Although the propofol loss in our experiments was
also smaller for chilled samples, a more constant concentra-
tion could not be determined. Furthermore, the stability of
International Journal of Analytical Chemistry 7
propofol in Tenax tubes may also depend on the exhaled
matrix itself. We cannot rule out that other volatile com-
pounds affect the stability of propofol and the sampling
technique might have an impact on the recovery as well.
5. Conclusions
Air shipment of propofol samples in Tenax tubes without
cooling shows unacceptable deviations from the initial con-
centration and is, therefore, not recommended.
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